Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 09.11.2026 UINC IE00BZBW4Z27 10,958,025.00 USD 467,787,218.81 42.689 ...
-
Lantern Pharma Announces Peer-Reviewed Publication of Phase 1a LP-184 Data in Recurrent Glioblastoma, Supporting a Phase 1b/2a Combination Trial with Spironolactone
DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company, and its wholly owned subsidiary Starlight Therapeutics today announced the publication of Phase 1a clinical data for LP-184 (zirdafulven) in patients with recurrent GBM. LP-184 is being developed as STAR-001 for central nervous system (CNS) cancers. The paper appears in the October 2026 issue of Cancer Research Communications, a peer-reviewed journal of the American Association fo...
-
Owlet Expands Into Everyday Family Health With Launch of Smart Thermometer
LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. ("Owlet" or the "Company") (NYSE: OWLT), the pioneer of smart infant monitoring and maker of the #1 best-selling smart baby monitor,* announced the launch of the Owlet® Smart Thermometer, an FDA-registered, non-contact infrared forehead thermometer that delivers clinically accurate temperature readings in one second. The launch extends Owlet’s capabilities beyond sleep and overnight monitoring and into a product category found in nearly every home with ch...
-
ニールセンIQ、2026年J.P.モルガン・アルティメット・サービス投資家カンファレンスでプレゼンテーションを実施
シカゴ--(BUSINESS WIRE)--(ビジネスワイヤ) -- 世界的な消費者インテリジェンス企業であるニールセンIQ(NYSE:NIQ)(以下「NIQ」)は、会長兼CEOのジム・ペックとCFOのマイク・バーウェルが、2026年11月17日(火)午後2時40分(米国東部時間)に開催されるJ.P.モルガン・アルティメット・サービス投資家カンファレンスにおいて、炉辺談話形式のプレゼンテーションを行うことを発表しました。プレゼンテーションのライブ配信は、NIQの投資家向けウェブサイト(https://investors.nielseniq.com)でご覧いただけます。プレゼンテーション終了後には、同社ウェブサイトで録画版も公開されます。 ニールセンIQについて ニールセンIQ(NYSE:NIQ)は、消費者の購買行動に関する最も包括的な情報を提供する、業界をリードする消費者インテリジェンス企業です。比類のないグローバルデータ基盤、きめ細かな消費者・小売を対象とした測定、そして数十年にわたるAIモデリングのノウハウを組み合わせることで、NIQは企業が複雑なデータを確実な行動へと結びつける...
-
Otter.ai anuncia seu maior avanço multilíngue até o momento: 27 novos idiomas e recursos multilíngues
MOUNTAIN VIEW, Califórnia--(BUSINESS WIRE)--A Otter.ai, empresa responsável pela plataforma líder em anotações com IA e conhecimento conversacional, anunciou hoje sua maior expansão multilíngue: 27 novos idiomas, dos quais 13 estão disponíveis hoje e os outros 14 serão lançados em breve. A novidade inclui também a transcrição multilíngue, que reconhece e transcreve conversas à medida que os participantes alternam entre idiomas, tudo em uma única reunião. Equipes globais geralmente não trabalham...
-
Verint Appoints Abhi Sharma as Chief Product and Technology Officer
MELVILLE, N.Y.--(BUSINESS WIRE)--Verint® today announced the appointment of Abhi Sharma as chief product and technology officer (CPTO), a newly created role uniting product and technology under a single leader. Sharma brings decades of experience leading and scaling global technology organizations.“Our customers are getting real business outcomes now from AI in CX, and we’re building on that from a position of strength,” said Dave Rhodes, chief executive officer at Verint. “Abhi will lead produc...
-
ZURA Investors Have Opportunity to Join Zura Bio Limited Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)--ZURA Investors Have Opportunity to Join Zura Bio Limited Fraud Investigation with SBS Law...
-
Genetix Biotherapeutics to Present at Jefferies Global Healthcare Conference
SOMERVILLE, Mass.--(BUSINESS WIRE)--Genetix Biotherapeutics Inc., the commercial leader in genetic medicine for rare disease with a focus on hematology, today announced that the Company will present at the Jefferies Global Healthcare Conference in London on Monday, November 16, at 2:30 p.m. GMT. David Meek, Chief Executive Officer of Genetix, will provide the first public update on the Company's rapid transformation into a scalable, profitable commercial enterprise, highlighting continued comme...
-
Meta VR Glasses to Be First-Ever IMAX Certified VR Device
NEW YORK--(BUSINESS WIRE)--IMAX® Corporation (NYSE: IMAX) and Meta (NASDAQ: META) today announced an agreement to make the upcoming Meta VR Glasses the first-ever IMAX Enhanced® certified VR device and bring an updated IMAX app to the device. The IMAX app will bring the IMAX Experience to audiences in a brand-new way when the glasses debut in spring 2027. The collaboration is designed to bring audiences closer to the filmmaker’s vision through optimized picture and immersive sound, with select...
-
Digital.ai Appoints Former Informatica CFO Earl Fry to Board of Directors
RALEIGH, N.C.--(BUSINESS WIRE)--Digital.ai Appoints Former Informatica CFO Earl Fry to Board of Directors...